Jennifer C. Robinson

Prognostic Utility of Risk Enhancers and Coronary Artery Calcium Score Recommended in the 2018 ACC/AHA Multisociety Cholesterol Treatment Guidelines Over the Pooled Cohort Equation: Insights From 3 Large Prospective Cohorts

A. Briasoulis, L. Afonso, E. Akintoye, 2021, Journal of the American Heart Association.

Earlier treatment in adults with high lifetime risk of cardiovascular diseases: What prevention trials are feasible and could change clinical practice? Report of a National Heart, Lung, and Blood Institute (NHLBI) Workshop

Arleen F. Brown, A. Khera, P. Ridker, 2022, American journal of preventive cardiology.

Use of Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Geriatric Ischemic Stroke Patients: Are the Rates Right?

M. Suneja, M. Schroeder, E. Chrischilles, 2018, Journal of the American Heart Association.

Risk Patterns and Mortality in Postmenopausal Women Using Latent Class Analysis.

M. Hendryx, K. Margolis, Juhua Luo, 2021, American journal of preventive medicine.

Field methods in medical record abstraction: assessing the properties of comparative effectiveness estimates

J. Pendergast, E. Chrischilles, J. Brooks, 2014, BMC Health Services Research.

Comparing the Effects of a Stroke Medicine in Older Adults With and Without Chronic Kidney Disease

M. Suneja, M. Schroeder, E. Chrischilles, 2020 .